Kynan Eng

Therapy assisting systems for neurological and orthopedic rehabilitation. Prof. Dr. Stefan Hesse and his team developed pioneering electromechanical and robotic devices to assist therapists in helping patients in their rehabilitation after stroke or incomplete paraplegia. Devices like the Gait Trainer GT I or the arm trainer Reha-Slide as well as the Reha-Slide Duo have been the first devices on the market. The unique new overground gait training system The FLOAT, developed in close collaboration with the Balgrist in Zurich, as well as the updates Gait Trainer GTII complete the comprehensive offering of therapy assisting devices for lower extremities to help increase therapy intensity with practical and easy-to-use devices for therapists and patients.

iniLabs incubates neuromorphic technologies. Our founders have invented some of the key foundations of the field, and we continue to lead the world in neuromorphic engineering through our close collaboration with the Institute of Neuroinformatics at the University of Zurich and the ETH Zurich. We also created and sponsor the Misha Mahowald Prize for Neuromorphic Engineering, which recognizes outstanding achievements in the field. Our spin-off companies have deployed neuromorphic technologies to over 500 labs and companies around the world in industries including aerospace, automotive, consumer electronics, industrial vision and security.

Our founders invented the field of high-performance neuromorphic machine vision, and we continue to lead the way today. Our bio-inspired intelligent technology provides unprecedented advantages over conventional machine vision systems: ultra-low response latency, low data rates, high dynamic range and ultra-low power consumption. iniVation combines decades of world-leading R&D experience with the world's largest community of customers and partners across multiple industrial markets. Our customer community includes global top-10 companies in automotive, consumer electronics, and aerospace.

SynSense is a leading-edge neuromorphic computing company. It provides dedicated mixed-signal/fully digital neuromorphic processors which overcome the limitations of legacy von Neumann computers to provide an unprecedented combination of ultra-low power consumption and low-latency performance. SynSense is founded in March 2017 based on advances in neuromorphic computing hardware developed at the Institute of Neuroinformatics of the University of Zurich and ETH Zurich. SynSense is developing “full-stack” custom neuromorphic processors for a variety of artificial-intelligence (AI) edge-computing applications that require ultra-low-power and ultra-low-latency features, including autonomous robots, always-on co-processors for mobile and embedded devices, wearable health-care systems, security, IoT applications, and computing at the network edge.

SynSense is a leading-edge neuromorphic computing company. It provides dedicated mixed-signal/fully digital neuromorphic processors which overcome the limitations of legacy von Neumann computers to provide an unprecedented combination of ultra-low power consumption and low-latency performance. SynSense is founded in March 2017 based on advances in neuromorphic computing hardware developed at the Institute of Neuroinformatics of the University of Zurich and ETH Zurich. SynSense is developing “full-stack” custom neuromorphic processors for a variety of artificial-intelligence (AI) edge-computing applications that require ultra-low-power and ultra-low-latency features, including autonomous robots, always-on co-processors for mobile and embedded devices, wearable health-care systems, security, IoT applications, and computing at the network edge.

The revolutionary QuantActions mobile health platform provides real-time brain function insights. Our solution reduces the risk of employee burnout, depression, and sleep disorders. We are also pursuing early detection of brain diseases.

Therapy assisting systems for neurological and orthopedic rehabilitation. Prof. Dr. Stefan Hesse and his team developed pioneering electromechanical and robotic devices to assist therapists in helping patients in their rehabilitation after stroke or incomplete paraplegia. Devices like the Gait Trainer GT I or the arm trainer Reha-Slide as well as the Reha-Slide Duo have been the first devices on the market. The unique new overground gait training system The FLOAT, developed in close collaboration with the Balgrist in Zurich, as well as the updates Gait Trainer GTII complete the comprehensive offering of therapy assisting devices for lower extremities to help increase therapy intensity with practical and easy-to-use devices for therapists and patients.